Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis

Published:2006 Issue:11 Volume:26 Page:629-638
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Rosery Hubertus,Bergemann Rito,Marx Steven E,Boehnke Axel,Melnick Joel,Sterz Raimund,Williams Laura

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference31 articles.

1. Parathyroidectomy in Chronic Renal Failure: Has Medical Care Reduced the Need for Surgery?

2. Hyperparathyroidism in the hemodialysis population: A survey of 612 patients

3. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone

4. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis;Frontiers in Public Health;2021-07-21

2. Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital;BMC Health Services Research;2016-08-26

3. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease;NEFROLOGIA;2015

4. Sourcing Quality-of-Life Weights Obtained from Previous Studies: Theory and Reality in Korea;The Patient - Patient-Centered Outcomes Research;2014-02-28

5. Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder;Kidney International Supplements;2013-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3